Oncternal Therapeutics, Inc. (ONCT)
NASDAQ: ONCT · Real-Time Price · USD
1.140
0.00 (0.00%)
Nov 21, 2024, 11:16 AM EST - Market open
Oncternal Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -34.58 | -39.48 | -44.17 | -31.33 | -17.23 | -34.19 | |
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 18.09 | |
| Loss (Gain) From Sale of Investments | -0.99 | -1.63 | -0.08 | - | - | - | |
| Stock-Based Compensation | 6.81 | 7.5 | 7.43 | 5.88 | 1.56 | 0.51 | |
| Other Operating Activities | 0.13 | 0.17 | 0.18 | 0.17 | -0.15 | 1.36 | |
| Change in Accounts Payable | -0.94 | -1.77 | 0.96 | 0.82 | 0.27 | -4.76 | |
| Change in Unearned Revenue | - | - | - | -1.63 | -2.01 | 3.64 | |
| Change in Other Net Operating Assets | 2.93 | 3.04 | -1.03 | -0.48 | 0.06 | -1.39 | |
| Operating Cash Flow | -26.63 | -32.16 | -36.7 | -26.59 | -17.5 | -16.75 | |
| Cash Acquisitions | - | - | - | - | - | 16.14 | |
| Investment in Securities | 24.87 | 0.65 | -26.5 | - | - | - | |
| Investing Cash Flow | 24.87 | 0.65 | -26.5 | - | - | 16.14 | |
| Long-Term Debt Issued | - | - | - | - | 0.3 | - | |
| Net Debt Issued (Repaid) | - | - | - | - | 0.3 | - | |
| Issuance of Common Stock | 0.04 | 1.26 | 9.96 | 0.62 | 113.88 | 0.02 | |
| Repurchase of Common Stock | -0.09 | -0.16 | -0 | - | - | - | |
| Other Financing Activities | -0.04 | -0.04 | -0.38 | - | - | - | |
| Financing Cash Flow | -0.09 | 1.07 | 9.58 | 0.62 | 114.18 | 0.02 | |
| Net Cash Flow | -1.85 | -30.45 | -53.62 | -25.97 | 96.69 | -0.59 | |
| Free Cash Flow | -26.63 | -32.16 | -36.7 | -26.59 | -17.5 | -16.75 | |
| Free Cash Flow Margin | -1232.39% | -4097.32% | -2463.36% | -616.20% | -518.37% | -690.56% | |
| Free Cash Flow Per Share | -9.01 | -10.94 | -13.96 | -10.78 | -17.23 | -32.43 | |
| Levered Free Cash Flow | -12.39 | -19.38 | -19.93 | -14.98 | -11.36 | -6.14 | |
| Unlevered Free Cash Flow | -12.39 | -19.38 | -19.93 | -14.98 | -11.36 | -6.14 | |
| Change in Net Working Capital | -2.58 | 0.81 | -0.73 | 1.25 | 1.95 | -2.74 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.